Huons Co., Ltd. acquires stake in PanGen to accelerate biopharmaceutical development
11/07/24, 2:17 PM
Location
seongnam si
durhamIndustry
biopharma
biotechnology
manufacturing
biotechnology
manufacturing
Huons Co., Ltd. has announced the acquisition of a significant stake in PanGen Biotech Inc. The acquisition is aimed at expanding Huons' biopharmaceutical research and development expertise, as well as strengthening its contract development and manufacturing organization (CDMO) business. This strategic move is expected to enhance Huons' global competitiveness and lead to synergies between affiliates.
Company Info
Location
Seongnam Si, Gyeonggi, South Korea
Company info
Huons BioPharma is a leading Korean manufacturer of botulinum toxin type-A (HUTOX, LIZTOX), specializing in innovative healthcare solutions. As a part of Huons Group, we leverage our expertise to develop and commercialize high-quality bio-pharmaceutical products for various therapeutic applications. With an intense focus on R&D, we are committed to advancing healthcare and improving patient outcomes.